Zachary Crees, Armin Ghobadi, Elizabeth Budde, Ahmed Galal, Chenyu Lin, Donghoon Choi, Sun-Kyoung Im, Hye Jeong, Alex Oh, Michael Rettig, John DiPersio. "A Phase 1 study evaluating NT-I7 (efineptakin alfa), a long-acting human IL-7, post-tisagenlecleucel (tisa-cel), post-axicabtagene ciloleucel (axi-cel), or post-lisocabtagene maraleucel (liso-cel) in Relapsed/Refractory large B-cell lymphoma." Blood, 2025. doi:10.1182/blood-2025-926